Postoperative Crohn’s disease: prevention and treatment

References

• Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann. Surg.231, 38–45 (2000).
   PubMed Web of Science ®Google Scholar
• Katz JA. Postoperative endoscopic surveillance in Crohn’s disease: bottom up or top down? Gastrointest. Endosc.66, 541–543 (2007).
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn’s disease remains uncertain. Gastroenterology127, 990–993 (2004).
   PubMed Web of Science ®Google Scholar
• Ng SC, Kamm MA. Management of postoperative Crohn’s disease. Am. J. Gastroenterol.103, 1029–1035 (2008).
   PubMed Web of Science ®Google Scholar
• Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut33, 331–335 (1992).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P. Review article: recurrence of Crohn’s disease after surgery – the need for treatment of new lesions. Aliment. Pharmacol. Ther.24(Suppl. 3), 29–32 (2006).
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut29, 588–592 (1988).
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology115, 259–267 (1998).
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology127, 723–729 (2004).
   PubMed Web of Science ®Google Scholar
• Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Ann. Surg.214, 230–238; discussion 238–240 (1991).
   PubMed Web of Science ®Google Scholar
• Sachar DB. The problem of postoperative recurrence of Crohn’s disease. Med. Clin. North Am.74, 183–188 (1990).
   PubMed Web of Science ®Google Scholar
• Terdiman JP. Prevention of postoperative recurrence in Crohn’s disease. Clin. Gastroenterol. Hepatol.6, 616–620 (2008).
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Factors affecting recurrence after surgery for Crohn’s disease. World J. Gastroenterol.11, 3971–3979 (2005).
   PubMed Web of Science ®Google Scholar
• Blum E, Katz JA. Postoperative therapy for Crohn’s disease. Inflamm. Bowel Dis.15, 463–472 (2009).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology99, 956–963 (1990).
   PubMed Web of Science ®Google Scholar
• Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment. Pharmacol. Ther.28, 545–556 (2008).
   PubMed Web of Science ®Google Scholar
• Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National Cooperative Crohn’s Disease Study: factors determining recurrence of Crohn’s disease after surgery. Gastroenterology77, 907–913 (1979).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Goboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet338, 771–774 (1991).
   PubMed Web of Science ®Google Scholar
• Cameron JL, Hamilton SR, Coleman J, Sitzmann JV, Bayless TM. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann. Surg.215, 546–551; discussion 551–552 (1992).
   PubMed Web of Science ®Google Scholar
• D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology114, 262–267 (1998).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut25, 665–672 (1984).
   PubMed Web of Science ®Google Scholar
• Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr. Opin. Gastroenterol.22, 377–381 (2006).
   PubMed Web of Science ®Google Scholar
• Bourreille A, Jarry M, D’Halluin PN et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut55, 978–983 (2006).
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment. Pharmacol. Ther.27, 146–154 (2008).
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology110, 424–431 (1996).
   PubMed Web of Science ®Google Scholar
• Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology106, 643–648 (1994).
   PubMed Web of Science ®Google Scholar
• Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J. Clin. Gastroenterol.39, 32–35 (2005).
   PubMed Web of Science ®Google Scholar
• Avidan B, Sakhnini E, Lahat A et al. Risk factors regarding the need for a second operation in patients with Crohn’s disease. Digestion72, 248–253 (2005).
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn’s disease. Gastroenterology98, 1123–1128 (1990).
   PubMed Web of Science ®Google Scholar
• Sachar DB, Lemmer E, Ibrahim C et al. Recurrence patterns after first resection for stricturing or penetrating Crohn’s disease. Inflamm. Bowel Dis. DOI: 10.1002/ibd.20872 (2009) (Epub ahead of print).
   Google Scholar
• Poggioli G, Laureti S, Selleri S et al. Factors affecting recurrence in Crohn’s disease. Results of a prospective audit. Int. J. Colorectal Dis.11, 294–298 (1996).
   PubMed Web of Science ®Google Scholar
• Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn’s disease. Dis. Colon Rectum29, 495–502 (1986).
   PubMed Web of Science ®Google Scholar
• Unkart JT, Anderson L, Li E et al. Risk factors for surgical recurrence after ileocolic resection of Crohn’s disease. Dis. Colon Rectum51, 1211–1216 (2008).
   PubMed Web of Science ®Google Scholar
• Ewe K, Herfarth C, Malchow H, Jesdinsky HJ. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion42, 224–232 (1989).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand. J. Gastroenterol.34, 708–713 (1999).
   PubMed Web of Science ®Google Scholar
• Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A; Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Prognostic factors for postoperative recurrence of Crohn’s disease. Dis. Colon Rectum39, 335–341 (1996).
   PubMed Web of Science ®Google Scholar
• Scarpa M, Ruffolo C, Bertin E et al. Surgical predictors of recurrence of Crohn’s disease after ileocolonic resection. Int. J. Colorectal Dis.22, 1061–1069 (2007).
   PubMed Web of Science ®Google Scholar
• Bergamaschi R, Pessaux P, Arnaud JP. Comparison of conventional and laparoscopic ileocolic resection for Crohn’s disease. Dis. Colon Rectum46, 1129–1133 (2003).
   PubMed Web of Science ®Google Scholar
• Regueiro M. Management and prevention of postoperative Crohn’s disease. Inflamm. Bowel Dis. DOI: 10.1002/ibd.20909 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Lochs H, Mayer M, Fleig WE et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European Cooperative Crohn’s Disease Study VI. Gastroenterology118, 264–273 (2000).
   PubMed Web of Science ®Google Scholar
• McLeod RS, Wolff BG, Steinhart AH et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology109, 404–413 (1995).
   PubMed Web of Science ®Google Scholar
• Brignola C, Cottone M, Pera A et al.; Italian Cooperative Study Group. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn’s disease. Gastroenterology108, 345–349 (1995).
   PubMed Web of Science ®Google Scholar
• Caprilli R, Cottone M, Tonelli F et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn’s disease: a pragmatic, double-blind, randomized controlled trial. Aliment. Pharmacol. Ther.17, 517–523 (2003).
   PubMed Web of Science ®Google Scholar
• Lemann M. Review article: can post-operative recurrence in Crohn’s disease be prevented? Aliment. Pharmacol. Ther.24(Suppl. 3), 22–28 (2006).
   PubMed Web of Science ®Google Scholar
• Cottone M, Camma C. Mesalamine and relapse prevention in Crohn’s disease. Gastroenterology119, 597 (2000).
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Martin F, Bailey RJ et al.; The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease. Gastroenterology112, 1069–1077 (1997).
   PubMed Web of Science ®Google Scholar
• Florent C, Cortot A, Quandale P et al.; Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn’s disease. Eur. J. Gastroenterol. Hepatol.8, 229–233 (1996).
   PubMed Web of Science ®Google Scholar
• Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst. Rev.4, CD000301 (2003).
   Google Scholar
• Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF; German Budesonide Study Group. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn’s disease: a multicentre randomized placebo-controlled trial. Eur. J. Gastroenterol. Hepatol.11, 277–282 (1999).
   PubMed Web of Science ®Google Scholar
• Hellers G, Cortot A, Jewell D et al.; The IOIBD Budesonide Study Group. Oral budesonide for prevention of postsurgical recurrence in Crohn’s disease. Gastroenterology116, 294–300 (1999).
   PubMed Web of Science ®Google Scholar
• Van Gossum A, Dewit O, Louis E et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after lleo-caecal resection. Inflamm. Bowel Dis.13, 135–142 (2007).
   PubMed Web of Science ®Google Scholar
• Marteau P, Lemann M, Seksik P et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut55, 842–847 (2006).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology108, 1617–1621 (1995).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology128, 856–861 (2005).
   PubMed Web of Science ®Google Scholar
• Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane Database Syst. Rev.2, CD000545 (2000).
   Google Scholar
• Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann. Intern. Med.123, 132–142 (1995).
   PubMed Web of Science ®Google Scholar
• Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintaining remission of Crohn’s disease. Cochrane Database Syst. Rev.2, CD000067 (2000).
   Google Scholar
• Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut54, 237–241 (2005).
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology127, 730–740 (2004).
   PubMed Web of Science ®Google Scholar
• Domenech E, Manosa M, Bernal I et al. Impact of azathioprine on the prevention of postoperative Crohn’s disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm. Bowel Dis.14, 508–513 (2008).
   PubMed Web of Science ®Google Scholar
• D’Haens GR, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology135, 1123–1129 (2008).
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Avellini C, Beltrami CA, Bresadola V, Toso F. Prevention of postoperative recurrence of Crohn’s disease by infliximab. Eur. J. Gastroenterol. Hepatol.18, 457–459 (2006).
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch. Intern. Med.167, 1804–1807 (2007).
   PubMedGoogle Scholar
• Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology136, 441–450 (2009).
   PubMed Web of Science ®Google Scholar
• Colombel JF, Rutgeerts P, Malchow H et al. Interleukin 10 (Tenovil™) in the prevention of postoperative recurrence of Crohn’s disease. Gut49, 42–46 (2001).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment. Pharmacol. Ther.25, 67–72 (2007).
   PubMed Web of Science ®Google Scholar